针对α-1抗素缺乏症的增强疗法:患者对自输注,家庭提供者和诊所的经验
Charlie Strange1,2, Sheri Allison2, Jean McCathern2
1Medical University of South Carolina, Charleston, South Carolina, United States.
Chronic obstructive pulmonary diseases (Miami, Fla.)
|August 7, 2023
概括
对患者来说,自给注射α-1抗素 (AAT) 是一个可行的,令人满意的选择. 这种方法提供了灵活性和便利性,许多患者表达了高度满意和愿意考虑它.
科学领域:
- 肺部医学 肺部医学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 静脉注射疗法是对α-1抗素缺乏症 (AATD) 的标准.
- 美国AATD输液方法的实用性和患者人口统计需要进一步描述.
研究的目的:
- 调查美国不同α-1抗素输液实践的流行情况.
- 了解患者报告的各种AATD输液方法相关的原因,挑战和益处.
主要方法:
- 在2022年2月8日至7月1日期间,对5266名AlphaNet疾病管理参与者进行了调查.
- 收集的数据包括当前/过去的输液实践,选择原因,遇到的问题和使用的支持服务.
主要成果:
- 医疗保健提供者 (60.2%) 和输液诊所 (30.6%) 的家庭输液是最常见的,但自输液 (8.1%) 随着治疗持续时间的增加而增加,并且在年轻患者中更为普遍.
- 自给注射的关键好处包括自由,旅行能力,避免去诊所,节省时间和减少工作缺勤.
- 自我灌注者报告了更高的满意度 (93.1%"非常满意"),而21.4%的非自我灌注者将在未来考虑它.
结论:
- 自给注射α-1抗素是一种可行的,非常令人满意的AATD管理方法.
- 研究结果支持制定导管护理,输液支持和自我输液实践的成本效益方面的建议.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
263
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
263
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Cystic Fibrosis: Management
194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
194
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244


